Markets:

Overview

News

Currencies

International

Treasuries

OS Therapies Incorporated Common Stock (NY:OSTX)

1.460 +0.060 (+4.29%)

Streaming Delayed Price Updated: 2:38 PM EST, Mar 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about OS Therapies Incorporated Common Stock

Why Quantum Computing Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

November 17, 2025

Via Benzinga

OS Therapies Reports Strong 2-Year Survival Data For Bone Cancer Immunotherapy Candidate ↗

October 10, 2025

OS Therapies reports 75% two-year survival in osteosarcoma trial, plans regulatory filings with the FDA, EMA, and MHRA following positive Phase 2b results.

Via Benzinga

Os Therapies Posts Wider Loss in Q2 ↗

August 19, 2025

Via The Motley Fool

Topics Intellectual Property

Earnings Outlook For OS Therapies ↗

August 18, 2025

Via Benzinga

OSTX Stock Earnings: OS Therapies Reported Results for Q2 2024 ↗

August 25, 2024

OS Therapies just reported results for the second quarter of 2024.

Via InvestorPlace

Which stocks are gapping on Monday? ↗

April 28, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 20, 2025

Via Benzinga

Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer ↗

February 14, 2025

OS Therapies advances OST-HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

Via Benzinga

Friday's session: gap up and gap down stocks ↗

February 14, 2025

The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Top movers in Friday's pre-market session ↗

February 14, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 31, 2025

Via Benzinga

Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why ↗

January 21, 2025

Cancer treatments, FDA breakthroughs, and other developments fueled a sharp spike in interest for these biotech players, as investors bet on promising clinical data and strategic moves.

Via Stocktwits

Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday? ↗

January 15, 2025

OS Therapies shares Phase 2b trial results showing OST-HER2 improves survival rates in rare metastatic osteosarcoma, surpassing historical controls.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 03, 2024

Via Benzinga

Transforming Cancer Therapy Stocks to Watch In The Oncology Sector

September 12, 2024

Transforming Cancer Therapy Stocks to Watch In The Oncology Sector

Via News Direct

Transforming Oncology: Stocks to Watch in the Oncology Sector

September 12, 2024

Transforming Oncology: Stocks to Watch in the Oncology Sector

Via News Direct

Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2024

Via Benzinga

OS Therapies Falls Following Downsized IPO ↗

August 04, 2024

Shares of OS Therapies fell on Thursday following a downsized initial public offering by the oncology drug developer in a slow week for the IPO market.

Via Talk Markets

Topics Initial Public Offering

Dow Dips Over 400 Points; Apple Posts Upbeat Earnings ↗

August 02, 2024

Via Benzinga

Topics Stocks

Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket ↗

August 02, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.